Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Apr;77(7):1089–1096. doi: 10.1038/bjc.1998.181

Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.

T Oguri 1, Y Fujiwara 1, T Isobe 1, O Katoh 1, H Watanabe 1, M Yamakido 1
PMCID: PMC2150117  PMID: 9569044

Abstract

We examined the steady-state levels of mRNA for gamma-glutamylcysteine synthetase (gamma-GCS), multidrug resistance-associated protein (MRP) and human canalicular multispecific organic anion transporter (cMOAT) in human lung cancer specimens to elucidate their roles in relation to platinum drug resistance in vivo. Seventy-six autopsy samples (38 primary tumours and their corresponding normal lung tissues) obtained from 38 patients were analysed using the quantitative reverse transcription polymerase chain reaction (RT-PCR) method. Both subunits (heavy and light subunits) of gamma-GCS expression levels of normal lung and tumour tissues exposed to platinum drugs during life were significantly higher than those of non-exposed tissues, whereas only the MRP expression levels of tumours were elevated in association with ante-mortem platinum drug exposure. The gamma-GCS and MRP expression levels correlated significantly. The cMOAT expression levels did not correlate with ante-mortem platinum drug exposure. Next, we monitored gamma-GCS heavy subunit expression levels in peripheral mononuclear cells of eight previously untreated lung cancer patients after platinum drug administration, which revealed that these drugs induced gamma-GCS expression in vivo. These results suggest that gamma-GCS expression is induced by platinum drugs in vivo and/or the physiological stress response to xenobiotics.

Full text

PDF
1089

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey H. H., Gipp J. J., Ripple M., Wilding G., Mulcahy R. T. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res. 1992 Sep 15;52(18):5115–5118. [PubMed] [Google Scholar]
  2. Bungo M., Fujiwara Y., Kasahara K., Nakagawa K., Ohe Y., Sasaki Y., Irino S., Saijo N. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res. 1990 May 1;50(9):2549–2553. [PubMed] [Google Scholar]
  3. Büchler M., König J., Brom M., Kartenbeck J., Spring H., Horie T., Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem. 1996 Jun 21;271(25):15091–15098. doi: 10.1074/jbc.271.25.15091. [DOI] [PubMed] [Google Scholar]
  4. Chuman Y., Chen Z. S., Sumizawa T., Furukawa T., Haraguchi M., Takebayashi Y., Niwa K., Yamada K., Aikou T., Akiyama S. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells. Biochem Biophys Res Commun. 1996 Sep 4;226(1):158–165. doi: 10.1006/bbrc.1996.1326. [DOI] [PubMed] [Google Scholar]
  5. Fujii R., Mutoh M., Sumizawa T., Chen Z. S., Yoshimura A., Akiyama S. Adenosine triphosphate-dependent transport of leukotriene C4 by membrane vesicles prepared from cisplatin-resistant human epidermoid carcinoma tumor cells. J Natl Cancer Inst. 1994 Dec 7;86(23):1781–1784. doi: 10.1093/jnci/86.23.1781. [DOI] [PubMed] [Google Scholar]
  6. Fujiwara Y., Sugimoto Y., Kasahara K., Bungo M., Yamakido M., Tew K. D., Saijo N. Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res. 1990 May;81(5):527–535. doi: 10.1111/j.1349-7006.1990.tb02602.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gipp J. J., Bailey H. H., Mulcahy R. T. Cloning and sequencing of the cDNA for the light subunit of human liver gamma-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues. Biochem Biophys Res Commun. 1995 Jan 17;206(2):584–589. doi: 10.1006/bbrc.1995.1083. [DOI] [PubMed] [Google Scholar]
  8. Gipp J. J., Chang C., Mulcahy R. T. Cloning and nucleotide sequence of a full-length cDNA for human liver gamma-glutamylcysteine synthetase. Biochem Biophys Res Commun. 1992 May 29;185(1):29–35. doi: 10.1016/s0006-291x(05)80950-7. [DOI] [PubMed] [Google Scholar]
  9. Godwin A. K., Meister A., O'Dwyer P. J., Huang C. S., Hamilton T. C., Anderson M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3070–3074. doi: 10.1073/pnas.89.7.3070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goto S., Yoshida K., Morikawa T., Urata Y., Suzuki K., Kondo T. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res. 1995 Oct 1;55(19):4297–4301. [PubMed] [Google Scholar]
  11. Grant C. E., Valdimarsson G., Hipfner D. R., Almquist K. C., Cole S. P., Deeley R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 1994 Jan 15;54(2):357–361. [PubMed] [Google Scholar]
  12. Huang C. S., Chang L. S., Anderson M. E., Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem. 1993 Sep 15;268(26):19675–19680. [PubMed] [Google Scholar]
  13. Ishikawa T., Ali-Osman F. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. J Biol Chem. 1993 Sep 25;268(27):20116–20125. [PubMed] [Google Scholar]
  14. Ishikawa T., Bao J. J., Yamane Y., Akimaru K., Frindrich K., Wright C. D., Kuo M. T. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem. 1996 Jun 21;271(25):14981–14988. doi: 10.1074/jbc.271.25.14981. [DOI] [PubMed] [Google Scholar]
  15. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res. 1994 Sep 15;54(18):4833–4836. [PubMed] [Google Scholar]
  16. Kleiner D. E., Emmert-Buck M. R., Liotta L. A. Necropsy as a research method in the age of molecular pathology. Lancet. 1995 Oct 7;346(8980):945–948. doi: 10.1016/s0140-6736(95)91561-3. [DOI] [PubMed] [Google Scholar]
  17. Kondo T., Yoshida K., Urata Y., Goto S., Gasa S., Taniguchi N. gamma-Glutamylcysteine synthetase and active transport of glutathione S-conjugate are responsive to heat shock in K562 erythroid cells. J Biol Chem. 1993 Sep 25;268(27):20366–20372. [PubMed] [Google Scholar]
  18. Kuo M. T., Bao J. J., Curley S. A., Ikeguchi M., Johnston D. A., Ishikawa T. Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res. 1996 Aug 15;56(16):3642–3644. [PubMed] [Google Scholar]
  19. Kurokawa H., Ishida T., Nishio K., Arioka H., Sata M., Fukumoto H., Miura M., Saijo N. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochem Biophys Res Commun. 1995 Nov 2;216(1):258–264. doi: 10.1006/bbrc.1995.2618. [DOI] [PubMed] [Google Scholar]
  20. Mitsuhashi M., Cooper A., Ogura M., Shinagawa T., Yano K., Hosokawa T. Oligonucleotide probe design--a new approach. Nature. 1994 Feb 24;367(6465):759–761. doi: 10.1038/367759a0. [DOI] [PubMed] [Google Scholar]
  21. Mulcahy R. T., Bailey H. H., Gipp J. J. Transfection of complementary DNAs for the heavy and light subunits of human gamma-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res. 1995 Nov 1;55(21):4771–4775. [PubMed] [Google Scholar]
  22. Mulcahy R. T., Bailey H. H., Gipp J. J. Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother Pharmacol. 1994;34(1):67–71. doi: 10.1007/BF00686114. [DOI] [PubMed] [Google Scholar]
  23. Mulcahy R. T., Gipp J. J. Identification of a putative antioxidant response element in the 5'-flanking region of the human gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Biophys Res Commun. 1995 Apr 6;209(1):227–233. doi: 10.1006/bbrc.1995.1493. [DOI] [PubMed] [Google Scholar]
  24. Müller M., Meijer C., Zaman G. J., Borst P., Scheper R. J., Mulder N. H., de Vries E. G., Jansen P. L. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):13033–13037. doi: 10.1073/pnas.91.26.13033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'Brien M. L., Tew K. D. Glutathione and related enzymes in multidrug resistance. Eur J Cancer. 1996 Jun;32A(6):967–978. doi: 10.1016/0959-8049(96)00051-2. [DOI] [PubMed] [Google Scholar]
  26. O'Dwyer P. J., Szarka C. E., Yao K. S., Halbherr T. C., Pfeiffer G. R., Green F., Gallo J. M., Brennan J., Frucht H., Goosenberg E. B. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J Clin Invest. 1996 Sep 1;98(5):1210–1217. doi: 10.1172/JCI118904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ohashi N., Fujiwara Y., Yamaoka N., Katoh O., Satow Y., Yamakido M. No alteration in DNA topoisomerase I gene related to CPT-11 resistance in human lung cancer. Jpn J Cancer Res. 1996 Dec;87(12):1280–1287. doi: 10.1111/j.1349-7006.1996.tb03144.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Paulusma C. C., Bosma P. J., Zaman G. J., Bakker C. T., Otter M., Scheffer G. L., Scheper R. J., Borst P., Oude Elferink R. P. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 1996 Feb 23;271(5252):1126–1128. doi: 10.1126/science.271.5252.1126. [DOI] [PubMed] [Google Scholar]
  29. Stewart D. J., Grewaal D., Redmond M. D., Mikhael N. Z., Montpetit V. A., Goel R., Green R. M. Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide. Cancer Chemother Pharmacol. 1993;32(5):368–372. doi: 10.1007/BF00735921. [DOI] [PubMed] [Google Scholar]
  30. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S., Kuwano M. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res. 1996 Sep 15;56(18):4124–4129. [PubMed] [Google Scholar]
  31. Tothill P., Klys H. S., Matheson L. M., McKay K., Smyth J. F. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Eur J Cancer. 1992;28A(8-9):1358–1361. doi: 10.1016/0959-8049(92)90519-8. [DOI] [PubMed] [Google Scholar]
  32. Yao K. S., Godwin A. K., Johnson S. W., Ozols R. F., O'Dwyer P. J., Hamilton T. C. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. Cancer Res. 1995 Oct 1;55(19):4367–4374. [PubMed] [Google Scholar]
  33. Yao K., Godwin A. K., Ozols R. F., Hamilton T. C., O'Dwyer P. J. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment. Cancer Res. 1993 Aug 15;53(16):3662–3666. [PubMed] [Google Scholar]
  34. Zhu Q., Center M. S. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res. 1994 Aug 15;54(16):4488–4492. [PubMed] [Google Scholar]
  35. de Vries E. G., Müller M., Meijer C., Jansen P. L., Mulder N. H. Role of the glutathione S-conjugate pump in cisplatin resistance. J Natl Cancer Inst. 1995 Apr 5;87(7):537–538. doi: 10.1093/jnci/87.7.537. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES